The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to rampant hospitalizations. The most at-risk populations for developing severe disease include – the elderly; infants and neonates; and individuals with pre-existing heart, respiratory, metabolic, and autoimmune…
Read More
Study finds correlation between neutralizing antibody titer and reported vaccine efficacy
An observational study compares immune responses against three vaccines: BNT162b2 (Pfizer mRNA vaccine), mRNA-1273 (Moderna mRNA vaccine), and Ad26.COV2.S (J&J adenovirus vaccine). Study: Comparative analysis of human immune responses following SARS-CoV-2 vaccination with BNT162b2, mRNA-1273, or Ad26.COV2.S. Image Credit: DisobeyArt/…
Read More
Risk factors for long COVID-19 in children
After more than a year of the coronavirus disease 2019 (COVID-19) pandemic, it has become clear that children are less susceptible to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), both in terms of the number of infections and the…
Read More
SARS-CoV-2 antibody response robust in nursing home residents after Pfizer-BioNTech vaccine
The first wave of the coronavirus disease 2019 (COVID-19) pandemic was associated with significantly higher mortality among older people. As a result, this age group, particularly the vulnerable community living in long-term care facilities or nursing homes, was prioritized in…
Read More
India’s Covid-19 fatality rate drops to 1.46%; Govt targets bringing it down to 1%
India’s coronavirus disease (Covid-19) case fatality rate (CFR) dropped to 1.46% on Sunday, with 133,771 of 9,140,191 infected persons having succumbed to the viral infection in the country. The first death due to Covid-19 was reported in India on March…
Read More